Inventor
QUAY STEVEN C
US88 patents
⚠️ This page may combine multiple inventors who share the name “QUAY STEVEN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SONUS PHARMA INC
13 patentsUS6667048B1Dec 23, 2003
Emulsion vehicle for poorly soluble drugs
SONUS PHARMA INC194 citations99
US6458373B1Oct 1, 2002
Emulsion vehicle for poorly soluble drugs
SONUS PHARMA INC269 citations99
US5573751ANov 12, 1996
Persistent gaseous bubbles as ultrasound contrast media
SONUS PHARMA INC110 citations99
US5558854ASep 24, 1996
Ultrasound contrast media comprising perfluoropentane and perfluorohexane gas
SONUS PHARMA INC143 citations99
US5409688AApr 25, 1995
Gaseous ultrasound contrast media
SONUS PHARMA INC227 citations99
US5393524AFeb 28, 1995
Methods for selecting and using gases as ultrasound contrast media
SONUS PHARMA INC253 citations99
US6982282B2Jan 3, 2006
Emulsion vehicle for poorly soluble drugs
SONUS PHARMA INC69 citations98
US6660286B1Dec 9, 2003
Emulsion vehicle for poorly soluble drugs
SONUS PHARMA INC82 citations97
US6245319B1Jun 12, 2001
Colloidal dispersions of perfluoropentane
SONUS PHARMA INC16 citations93
US6156292ADec 5, 2000
Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
SONUS PHARMA INC18 citations93
US7030155B2Apr 18, 2006
Emulsion vehicle for poorly soluble drugs
SONUS PHARMA INC49 citations92
US5897851AApr 27, 1999
Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
SONUS PHARMA INC63 citations91
US6727280B2Apr 27, 2004
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
SONUS PHARMA INC36 citations90
SALUTAR INC
13 patentsUS4687658AAug 18, 1987
Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
SALUTAR INC77 citations96
US4687659AAug 18, 1987
Diamide-DTPA-paramagnetic contrast agents for MR imaging
SALUTAR INC118 citations96
US5219553AJun 15, 1993
Composition of a n-carboxymethylated tetraazacyclododecane chelating agent, a paramagnetic metal and excess calcium ions for MRI
SALUTAR INC54 citations94
US5039512AAug 13, 1991
NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes
SALUTAR INC52 citations94
US5087439AFeb 11, 1992
Paramagnetic metal-diethylenetriamine-pentaacetic acid partial amide complexes for magnetic resonance imaging
SALUTAR INC39 citations93
US4933456AJun 12, 1990
Dipyridoxyl phosphate NMRI contrast agents
SALUTAR INC29 citations93
US4758422AJul 19, 1988
Ferrioxamine paramagnetic contrast agents for MR imaging
SALUTAR INC40 citations93
US4637929AJan 20, 1987
Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
SALUTAR INC42 citations93
US5039511AAug 13, 1991
Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor
SALUTAR INC39 citations92
US5008099AApr 16, 1991
Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor
SALUTAR INC23 citations92
US4933156AJun 12, 1990
Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor
SALUTAR INC45 citations92
US6274713B1Aug 14, 2001
Polychelants
SALUTAR INC74 citations91
US4859451AAug 22, 1989
Paramagnetic contrast agents for MR imaging
SALUTAR INC55 citations91
NASTECH PHARM CO
6 patentsUS7166575B2Jan 23, 2007
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
NASTECH PHARM CO46 citations96
US7157426B2Jan 2, 2007
Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
NASTECH PHARM CO40 citations93
US7244709B2Jul 17, 2007
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
NASTECH PHARM CO26 citations91
US7229966B2Jun 12, 2007
Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
NASTECH PHARM CO20 citations90
US7186691B2Mar 6, 2007
Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
NASTECH PHARM CO22 citations90
US7186692B2Mar 6, 2007
Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
NASTECH PHARM CO15 citations83
ATOSSA HEALTHCARE INC
5 patentsUS6887210B2May 3, 2005
Devices and methods for obtaining mammary fluid samples for evaluating breast diseases, including cancer
ATOSSA HEALTHCARE INC114 citations98
US6689073B2Feb 10, 2004
Methods and devices for collecting, handling and processing mammary fluid samples for evaluating breast diseases, including cancer
ATOSSA HEALTHCARE INC58 citations96
US6287521B1Sep 11, 2001
Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer
ATOSSA HEALTHCARE INC219 citations96
US7128877B2Oct 31, 2006
Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer
ATOSSA HEALTHCARE INC42 citations94
US6894026B1May 17, 2005
Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
ATOSSA HEALTHCARE INC25 citations92
ATOSSA THERAPEUTICS INC
4 patentsUS11261151B2Mar 1, 2022
Methods for making and using endoxifen
ATOSSA THERAPEUTICS INC9 citations92
US12071391B2Aug 27, 2024
Methods for making and using endoxifen
ATOSSA THERAPEUTICS INC4 citations83
US11680036B1Jun 20, 2023
Methods for making and using endoxifen
ATOSSA THERAPEUTICS INC6 citations83
US11572334B2Feb 7, 2023
Methods for making and using endoxifen
ATOSSA THERAPEUTICS INC8 citations83
AMERSHAM HEALTH AS
2 patentsQUAY ENTPR LLC K
2 patentsSIEVING PAUL F
1 patentQUAY STEVEN C
1 patentQUAY ENTERPRISES LLC K
1 patentMDRNA INC
1 patentMARINA BIOTECH INC
1 patentShowing the top 50 of 88 patents by PatentIndex Score.